Category: BiometSyndicate content

SEMDA taps AdvaMed's Jason Rupp for executive director role |Personnel Moves

February 18, 2015 by Brian Johnson

Jason Rupp, former AdvaMed executive is named executive director for Southeastern Medical Device Association (SEMDA).

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

The Southeastern Medical Device Association (SEMDA) has named former AdvaMed executive Jason Rupp as its first full time executive director.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MDT's Ev3 pays $1.3m in whistleblower suit | The week in medtech M&A

February 11, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; GPOs: Premier buys the rest of direct sourcer S2S Global; CareFusion crushes it in final quarter; BD beats Q1 estimates, raises outlook, shares jump; Zimmer revises Biomet bid for EU regulators

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello

Zimmer revises Biomet bid for EU regulators

February 10, 2015 by Brad Perriello

Zimmer revises its $13 billion bid for crosstown rival Biomet in a further effort to mollify European anti-trust regulators, saying it thinks the deal is still on track to close during the 1st quarter.

Zimmer revises Biomet bid for EU regulators

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Zimmer's $13B Biomet merger on track to close in Q1

February 2, 2015 by Mark Hollmer

Zimmer and Biomet are on track to close their $13 billion merger in the 1st quarter, Zimmer CEO David Dvorak said during a conference call discussing the orthopedic giant's 4th-quarter results.

Zimmer's $13B Biomet merger on track to close in Q1

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biomet's Q2 profits surge on lower legal costs

January 6, 2015 by Brad Perriello

Biomet reports surging profits during its fiscal 2nd quarter, citing a nearly $70 million decrease in legal costs compared with the same period last year.

Biomet's Q2 profits surge on lower legal costs

Biomet reported surging 2nd-quarter profits today, saying a 61% reduction in legal costs drove the increase.

ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A

December 10, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy

Zimmer proposes divestitures for EU regulators in Biomet deal

December 4, 2014 by Brad Perriello

Zimmer proposes divestitures for EU regulators in Biomet deal

December 4, 2014 by Brad Perriello

Zimmer proposes to mollify European anti-trust regulators on its pending, $13 billion acquisition of rival Biomet by selling off some of its knee and elbow assets in Europe.

Zimmer proposes divestitures for EU regulators in Biomet deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.